new blood test for breast cancer

Release time ：Dec-24,2024

Emerging blood testing technologies offer the potential for early detection of breast cancer by identifying specific biomarkers in the bloodstream, which include circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other proteins or molecules associated with breast cancer. These blood tests are non-invasive, rapid, and easy to perform, and they hold promise as novel tools for breast cancer screening and surveillance, surpassing traditional imaging methods in terms of convenience.

However, it is important to recognize that these innovative blood tests are still under investigation, and their accuracy and reliability require further validation. Moreover, the results from blood tests should be interpreted in conjunction with other clinical data and imaging findings; they should not be relied upon as the sole basis for a breast cancer diagnosis. Consequently, a multi-modal approach remains essential for the screening and diagnosis of breast cancer.

Regular breast cancer screening is crucial for women. Should symptoms such as breast lumps, changes in skin texture, or nipple discharge arise, immediate medical consultation is advised. Additionally, adopting a healthy lifestyle—including abstaining from smoking, moderating alcohol intake, maintaining a balanced diet, and engaging in regular physical activity—can help reduce the risk of developing breast cancer. Lastly, the use of any medication should always be under the supervision of a healthcare provider and never be self-administered without proper guidance.